Relaxin antagonizes hypertrophy and apoptosis in neonatal rat cardiomyocytes

Endocrinology

Volumn 148, Issue 4, 2007, Pages 1582-1589

  Moore, Xiao Lei ^a   Tan, Su Ling ^a   Lo, Chen Yi ^a   Fang, Lu ^a   Su, Yi Dan ^a   Gao, Xiao Ming ^a   Woodcock, Elizabeth A ^a   Summers, Roger J ^c   Tregear, Geoffrey W ^b   Bathgate, Ross A D ^b   Du, Xiao Jun ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; DNA; HYDROGEN PEROXIDE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; PHENYLEPHRINE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; RELAXIN; RELAXIN 2; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION; HEART MUSCLE CELL; MUSCLE HYPERTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CARDIOMEGALY; CELL ENLARGEMENT; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; MYOCYTES, CARDIAC; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; RELAXIN; SIGNAL TRANSDUCTION;

EID: 33947379636     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-1324     Document Type: Article

References (55)

1. Hisaw FL 1926 Experimental relaxation of the pubic ligament of the guinea pig. Proc Soc Exp Biol Med 23:661-663
2. Sherwood OD 2004 Relaxin's physiological roles and other diverse actions. Endocr Rev 25:205-234
3. Conrad KP, Novak J 2004 Emerging role of relaxin in renal and cardiovascular function. Am J Physiol Regul Integr Comp Physiol 287:R250-R261
4. Samuel CS, Du XJ, Bathgate RA, Summers RJ 2006 'Relaxin' the stiffened heart and arteries: the therapeutic potential for relaxin in the treatment of cardiovascular disease. Pharmacol Ther 121:529-552
5. Du XJ, Samuel CS, Gao XM, Zhao L, Parry LJ, Tregear GW 2003 Increased myocardial collagen and ventricular diastolic dysfunction in relaxin deficient mice: a gender-specific phenotype. Cardiovasc Res 57:395-404
6. Lekgabe ED, Kiriazis H, Zhao C, Xu Q, Moore XL, Su Y, Bathgate RA, Du XJ 2005 Relaxin reverses cardiac and renal fibrosis in spontaneously hypertensive rats. Hypertension 46:412-418
7. Samuel CS, Unemori EN, Mookerjee I, Bathgate RA, Layfield SL, Mak J, Tregear GW, Du XJ 2004 Relaxin modulates cardiac fibroblast proliferation, differentiation, and collagen production and reverses cardiac fibrosis in vivo. Endocrinology 145:4125-4133
8. Bani D, Masini E, Bello MG, Bigazzi M, Sacchi TB 1998 Relaxin protects against myocardial injury caused by ischemia and reperfusion in rat heart. Am J Pathol 152:1367-1376
9. Perna AM, Masini E, Nistri S, Briganti V, Chiappini L, Stefano P, Bigazzi M, Pieroni C, Sacchi TB, Bani D 2005 Novel drug development opportunity for relaxin in acute myocardial infarction: evidences from a swine model. FASEB J 19:1525-1527
10. Fisher C, Berry C, Blue L, Morton JJ, McMurray J 2003 N-terminal pro B type natriuretic peptide, but not the new putative cardiac hormone relaxin, predicts prognosis in patients with chronic heart failure. Heart 89:879-881
11. Kruger S, Graf J, Merx MW, Stickel T, Kunz D, Hanrath P, Lanssens U 2004 Relaxin kinetics during dynamic exercise in patients with chronic heart failure. Eur J Intern Med 15:54-56
12. Kupari M, Mikkola TS, Turto H, Lommi J 2005 Is the pregnancy hormone relaxin an important player in human heart failure? Eur J Heart Fail 7:195-198
13. Dschietzig T, Richter C, Bartsch C, Laule M, Armbruster FP, Baumann G, Stangl K 2001 The pregnancy hormone relaxin is a player in human heart failure. FASEB J 15:2187-2195
14. Hocher B, Ziebig R, Krause R, Asmus G, Neumayer HH, Liefeldt L, Stasch JP 2004 Relaxin is an independent risk factor predicting death in male patients with end-stage kidney disease. Circulation 109:2266-2268
15. Ding B, Price RL, Goldsmith EC, Borg TK, Yan X, Douglas PS, Weinberg EO, Bartunek J, Thielen T, Didenko VV, Lorell BH 2000 Left ventricular hypertrophy in ascending aortic stenosis mice: anoikis and the progression to early failure. Circulation 101:2854-2862
16. Wencker D, Chandra M, Nguyen K, Miao W, Garantziotis S, Factor SM, Shirani J, Armstrong RC, Kitsis RN 2003 A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest 111:1497-1504
17. Gosse P 2005 Left ventricular hypertrophy as a predictor of cardiovascular risk. J Hypertens Suppl 23:S27-S33
18. Lee HY, Zhao S, Fields PA, Sherwood OD 2005 The extent to which relaxin promotes proliferation and inhibits apoptosis of cervical epithelial and stromal cells is greatest during late pregnancy in rats. Endocrinology 146:511-518
19. Dschietzig T, Bartsch C, Kinkel T, Baumann G, Stangl K 2005 Myocardial relaxin counteracts hypertrophy in hypertensive rats. Ann NY Acad Sci 1041:441-443
20. Woodcock EA, Wang BH, Arthur JF, Lennard A, Matkovich SJ, Du XJ, Brown JH, Hannan RD 2002 Inositol polyphosphate 1-phosphatase is a novel antihypertrophic factor. J Biol Chem 277:22734-22742
21. Halls ML, Bathgate RA, Summers RJ 2006 Relaxin family peptide receptors RXFP1 and RXFP2 modulate cAMP signaling by distinct mechanisms. Mol Pharmacol 70:214-226
22. Manabe I, Shindo T, Nagai R 2002 Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy. Circ Res 91:1103-1113
23. Rodriguez M, Schaper J 2005 Apoptosis: measurement and technical issues. J Mol Cell Cardiol 38:15-20
24. 2 regulates cardiac myocyte phenotype via concentration-dependent activation of distinct kinase pathways. J Mol Cell Cardiol 35:615-621
25. Toth M, Taskinen P, Ruskoaho H 1996 Relaxin stimulates atrial natriuretic peptide secretion in perfused rat heart. J Endocrinol 150:487-495
26. Rosenkranz AC, Woods RL, Dusting GJ, Ritchie RH 2003 Antihypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: importance of cyclic GMP. Cardiovasc Res 57:515-522
27. Gray MO, Long CS, Kalinyak JE, Li HT, Karliner JS 1998 Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts. Cardiovasc Res 40:352-363
28. Harada M, Itoh H, Nakagawa O, Ogawa Y, Miyamoto Y, Kuwahara K, Ogawa E, Igaki T, Yamashita J, Masuda I, Yoshimasa T, Tanaka I, Saito Y, Nakao K 1997 Significance of ventricular myocytes and nonmyocytes interaction during cardiocyte hypertrophy: evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes. Circulation 96:3737-3744
29. Kim NN, Villarreal FJ, Printz MP, Lee AA, Dillmann WH 1995 Trophic effects of angiotensin II on neonatal rat cardiac myocytes are mediated by cardiac fibroblasts. Am J Physiol 269:E426-E437
30. Brown RD, Ambler SK, Mitchell MD, Long CS 2005 The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. Annu Rev Pharmacol Toxicol 45:657-687
31. Zhao S, Fields PA, Sherwood OD 2001 Evidence that relaxin inhibits apoptosis in the cervix and the vagina during the second half of pregnancy in the rat. Endocrinology 142:2221-2229
32. Park JL, Lucchesi BR 1999 Mechanisms of myocardial reperfusion injury. Ann Thorac Surg 68:1905-1912
33. Masaki M, Izumi M, Oshima Y, Nakaoka Y, Kuroda T, Kimura R, Sugiyama S, Terai K, Kitakaze M, Yamauchi-Takihara K, Kawase I, Hirota H 2005 Smad1 protects cardiomyocytes from ischemia-reperfusion injury. Circulation 111:2752-2759
34. Unosawa S 2004 Effects of a left ventricular assist device on the myocardium in ischemia-reperfusion injury. Ann Thorac Cardiovasc Surg 10:350-356
35. Inagaki K, Chen L, Ikeno F, Lee FH, Imahashi KI, Bouley DM, Rezaee M, Yock PG, Murphy E, Mochy-Rosen D 2003 Inhibition of δ-protein kinase C protects against reperfusion injury of the ischemic heart in vivo. Circulation 108:2304-2307
36. Matsushita K, Iwanaga S, Oda T, Kimura K, Shimada M, Sano M, Umezawa A, Hata J, Ogawa S 2005 Interleukin-6/soluble interleukin-6 receptor complex reduces infarct size via inhibiting myocardial apoptosis. Lab Invest 85:1210-1223
37. Masini E, Nistri S, Vannacci A, Bani Sacchi T, Novelli A, Bani D 2004 Relaxin inhibits the activation of human neutrophils: involvement of the nitric oxide pathway. Endocrinology 145:1106-1112
38. Nistri S, Chiappini L, Sassoli C, Bani D 2003 Relaxin inhibits lipopolysaccharide-induced adhesion of neutrophils to coronary endothelial cells by a nitric oxide-mediated mechanism. FASEB J 17:2109-2111
39. Luque EH, Munoz de Toro MM, Ramos JG, Rodriguez HA, Sherwood OD 1998 Role of relaxin and estrogen in the control of eosinophilic invasion and collagen remodeling in rat cervical tissue at term. Biol Reprod 59:795-800
40. Masini E, Bani D, Bigazzi M, Mannaioni PF, Bani-Sacchi T 1994 Effects of relaxin on mast cells. In vitro and in vivo studies in rats and guinea pigs. J Clin Invest 94:1974-1980
41. Bani D, Bigazzi M, Masini E, Bani G, Sacchi TB 1995 Relaxin depresses platelet aggregation: in vitro studies on isolated human and rabbit platelets. Lab Invest 73:709-716
42. 2 contributes to reperfusion injury of ischemic skeletal muscle. Am J Physiol 258:H1415-H1419
43. Zhao ZQ 2004 Oxidative stress-elicited myocardial apoptosis during reperfusion. Curr Opin Pharmacol 4:159-165
44. Schulz R, Kelm M, Heusch G 2004 Nitric oxide in myocardial ischemia/reperfusion injury. Cardiovasc Res 61:402-413
45. Bathgate RA, Ivell R, Sanborn BM, Sherwood OD, Summers RJ 2006 International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides. Pharmacol Rev 58:7-31
46. Hsu SY, Nakabayashi K, Nishi S, Kumagai J, Kudo M, Sherwood OD, Hsueh AJ 2002 Activation of orphan receptors by the hormone relaxin. Science 295:671-674
47. Matsui T, Rosenzweig A 2005 Convergent signal transduction pathways controlling cardiomyocyte survival and function: the role of PI 3-kinase and Akt. J Mol Cell Cardiol 38:63-71
48. Baines CP, Molkentin JD 2005 STRESS signaling pathways that modulate cardiac myocyte apoptosis. J Mol Cell Cardiol 38:47-62
49. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME 1997 Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231-241
50. Ueda K, Takano H, Hasegawa H, Niitsuma Y, Qin Y, Ohtsuka M, Komuro I 2006 Granulocyte colony stimulating factor directly inhibits myocardial ischemia-reperfusion injury through Akt-endothelial NO synthase pathway. Arterioscler Thromb Vasc Biol 26:e108-e113
51. Xu Z, Park SS, Mueller RA, Bagnell RC, Patterson C, Boysen PG 2005 Adenosine produces nitric oxide and prevents mitochondrial oxidant damage in rat cardiomyocytes. Cardiovasc Res 65:803-812
52. Masini E, Zagli G, Ndisang JF, Solazzo M, Mannaioni PF, Bani D 2002 Protective effect of relaxin in cardiac anaphylaxis: involvement of the nitric oxide pathway. Br J Pharmacol 137:337-344
53. Henaff M, Hatem SN, Mercadier JJ 2000 Low catecholamine concentrations protect adult rat ventricular myocytes against apoptosis through cAMP-dependent extracellular signal-regulated kinase activation. Mol Pharmacol 58:1546-1553
54. Kuznetsova L, Plesneva S, Derjabina N, Omeljaniuk E, Pertseva M 1999 On the mechanism of relaxin action: the involvement of adenylyl cyclase signalling system. Regul Pept 80:33-39
55. Kompa AR, Samuel CS, Summers RJ 2002 Inotropic responses to human gene 2 (B29) relaxin in a rat model of myocardial infarction (MI): effect of pertussis toxin. Br J Pharmacol 137:710-718